Alafair is developing conformable, malleable and easily applied solutions to the problem of medical adhesion. These medical products utilize a porous polysaccharide-based hydrogel platform. Its solutions are applicable for anti-adhesive wound care and tissue reconstruction, and cosmetic fillers. The current market exceeds $1.2 billion dollars annually, and it’s growing.
Since participating in the TVL accelerator, Alafair has raised over $3.2 million in venture funding. The company is currently hiring to develop new products.